# FDA recall D-0836-2016

> **Hospira Inc.** · Class III · drug recall initiated 2016-03-15.

## Product

Quelicin (Succinylcholine Chloride) Injection, USP 200 mg. (20 mg/mL), 10 mL Multiple-dose vial, packaged in 25 Unit vials per carton, Rx only, HOSPIRA, INC., LAKE FOREST, IL 60045 USA,  NDC 0409-6629-02

## Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for the lot number and/or expiration date to be faded or missing from the primary label on the glass vial.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0836-2016
- **Recalling firm:** Hospira Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2016-03-15
- **Report date:** 2016-05-11

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0836-2016

## Citation

> AI Analytics. FDA recall D-0836-2016. Retrieved 2026-05-24 from https://api.ai-analytics.org/recall/D-0836-2016. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*